Indeed, in Wilms tumors, in which WT1 is biallelically mutated or deleted, Egr1 is upregulated, offering a dual synergistic mechanism for IGF2 increased transcriptional activation [89]. The gene discussed is IGF2; the disease is Nephroblastoma.